Send to

Choose Destination
Risk Anal. 2017 Jun;37(6):1041-1051. doi: 10.1111/risa.12823. Epub 2017 May 4.

Modeling and Managing the Risks of Measles and Rubella: A Global Perspective Part II.

Author information

Kid Risk, Inc., Orlando, FL, USA.
University of Central Florida, College of Medicine, Orlando, FL, USA.


Measles and rubella continue to circulate globally. Complementing Part I of the special issue, this introduction provides a contrast between other global eradication initiatives and the experience with measles and rubella eradication to date. This introduction builds on the syntheses of the literature provided in Part I and it describes the creation and application of a national risk assessment tool and the development of a dynamic disease transmission model to support global efforts to optimally manage measles and rubella globally using vaccines. Currently, efforts to eradicate measles and rubella suffer from the lack of a commitment to global eradication by key stakeholders, despite strong evidence that their eradication represents a better health and financial option than continued control.


Infectious disease; measles; modeling; rubella

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center